IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding IDEAYA Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 96 | −6 |
| Shares | 35.1M | 4.28K | 35.4M | +364.8K (+1.0%) |
| Value | $392.9M | $48.0K | $489.0M | +$96.1M (+24.5%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 24,876 | $343.0K | 0.00% |
| Alps Advisors Inc | 22,925 | $316.0K | 0.00% |
| Cornercap Investment Counsel Inc | 15,896 | $219.0K | 0.04% |
| State Board of Administration of Florida Retirement System | 12,453 | $172.0K | 0.00% |
| Lazard Asset Management LLC | 12,027 | $165.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,311 | $143.0K | 0.00% |
| Nisa Investment Advisors, LLC | 1,800 | $25.0K | 0.00% |
| Quadrant Capital Group LLC | 186 | $3.00K | 0.00% |
| Signaturefd, LLC | 81 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 43 | $1.00K | 0.00% |
Sold out (16)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Renaissance Technologies LLC | 196,537 | $2.20M |
| Marshall Wace, LLP | 166,805 | $1.87M |
| HRT Financial LP | 65,226 | $729.0K |
| Gsa Capital Partners LLP | 54,215 | $607.0K |
| Qube Research & Technologies Ltd | 48,838 | $546.0K |
| Bellevue Group AG | 46,200 | $517.0K |
| State of Wisconsin Investment Board | 42,900 | $480.0K |
| Acadian Asset Management LLC | 39,939 | $445.0K |
| D. E. Shaw & Co., Inc. | 24,590 | $275.0K |
| Principal Financial Group Inc | 18,997 | $213.0K |
| Trexquant Investment LP | 18,133 | $203.0K |
| HSBC Holdings PLC | 11,787 | $133.0K |
| ProShare Advisors LLC | 10,125 | $114.0K |
| Quantbot Technologies LP | 4,000 | $44.0K |
| Point72 Hong Kong Ltd | 3,376 | $38.0K |
| Howe & Rusling Inc | 40 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 4,278 | $48.0K |